More and more patients are surviving after a cancer
Published the 02.02.2018 at 12: 35
cancercancer of the poumoncancer of the breast
Survival after a cancer has increased in the world, according to the study, Concord-3, published on January 30 in the Lancet. Conducted from the data of 37.5 million patients from 71 countries, and with 18 the most common cancers between 2000 and 2014, the study demonstrated that the survival rate has increased in the United States, Canada, Australia, Finland, New Zealand, Norway, Switzerland and Iceland. On average, the survival rate has increased by five years.
China in advance for acute lymphoblastic leukemia
This is particularly the case in the American and Australian patients with cancer of the breast (90%), in 16 european countries (85%), India (66%) and eastern Europe (71%). Denmark and Sweden, late on certain diseases, show a survival rate of more than twice that in Brazil and Mexico. Similarly, 40 % of young Chinese patients with acute lymphoblastic leukemia (the most common cancer in the child) die, compared to only 10 % in the United States, Canada, and 9 western European countries.
Cancers of the lung and the liver, and the most deadly
Stomach cancer is a real public health problem in Russia, but is treated quite well in Japan, South Korea and South-East Asia. The results of the study also show that cancers of the liver and lungs are the most lethal, but that survival rates have improved in some regions of the world. Especially in South Korea (from 11% to 27 %), Portugal (8 to 19 %), Norway (6 to 19 %) and Switzerland (5 % to 17 %) for the first. The survival rate after cancer of the lungs has also improved in 21 european countries (7% to 13%), Japan (23% to 33%), China (8% and 20%) and South Korea (10% to 25%). Gastrointestinal cancers in South Asia have rates of survival up to 69 %.
150 000 deaths in France in 2017
Overall, this study demonstrates an improvement in the care of patients and treatments, but indicates that there is a clear disparity according to region of the world. The national cancer Institute (INCa) has identified 400, 000 new cases of cancer in France in 2017 and 150 000 deaths. “The mobilization is still necessary,” said the organization during the delivery of the annual report on the cancer plan 2014-2019. According to the INCa, the new cases of the most common cancers in men are prostate (no figures released on the year 2017), lung (32 300 new cases in 2017), and colon-rectum (24 000).